Anavex Life Sciences (AVXL) Treasury Shares (2013 - 2022)
Anavex Life Sciences (AVXL) reported Treasury Shares of $160000.0 for Q3 2022, down 23.81% on a YoY basis from $210000.0 in Q3 2021, and little changed sequentially from $160000.0 in Q2 2022.
Anavex Life Sciences (AVXL) Treasury Shares (2013 - 2022) Analysis & Trends
Anavex Life Sciences (AVXL) has 10 years of Treasury Shares data on file, last reported at $160000.0 in Q3 2022.
- For the quarter ending Q3 2022, Treasury Shares fell 23.81% year-over-year to $160000.0; the trailing twelve-month figure through Sep 2022 stood at $160000.0 (down 23.81% YoY), and the FY2022 full-year result was $160000.0, down 23.81% from the prior year.
- Treasury Shares held at $160000.0 in Q3 2022, from $160000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.6 million in Q1 2018 to a low of $160000.0 in Q4 2021.
- A 5-year average of $510217.2 and a median of $500000.0 in 2019 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares slumped 77.52% in 2019 and jumped 42.86% in 2020, its largest moves.
- Tracing AVXL's Treasury Shares over 5 years: stood at $678379.0 in 2018, then decreased by 26.29% to $500000.0 in 2019, then changed by 0.0% to $500000.0 in 2020, then plunged by 68.0% to $160000.0 in 2021, then changed by 0.0% to $160000.0 in 2022.
- Business Quant data shows AVXL's Treasury Shares at $160000.0 in Q3 2022, $160000.0 in Q2 2022, and $160000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Anavex Life Sciences | 229.83 Mn | 98.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 160,000.00 |
| Sep 30, 2022 | 160,000.00 |
| Jun 30, 2022 | 160,000.00 |
| Jun 30, 2022 | 160,000.00 |
| Mar 31, 2022 | 160,000.00 |
| Mar 31, 2022 | 160,000.00 |
| Dec 31, 2021 | 160,000.00 |
| Dec 31, 2021 | 160,000.00 |
| Sep 30, 2021 | 210,000.00 |
| Sep 30, 2021 | 210,000.00 |
| Jun 30, 2021 | 210,000.00 |
| Jun 30, 2021 | 210,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Dec 31, 2020 | 500,000.00 |
| Dec 31, 2020 | 500,000.00 |
| Sep 30, 2020 | 500,000.00 |
| Sep 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 500,000.00 |